Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor

Background. Pancreatic neuroendocrine tumors (NETs) are rare but are frequently diagnosed at advanced stages and require systemic therapy. Patients and methods. This multicenter, open-label, phase II study evaluated sunitinib in Japanese patients with well-differentiated pancreatic NET. Patients rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ito, Tetsuhide, Okusaka, Takuji, Nishida, Toshirou, Yamao, Kenji, Igarashi, Hisato, Morizane, Chigusa, Kondo, Shunsuke, Mizuno, Nobumasa, Hara, Kazuo, Sawaki, Akira, Hashigaki, Satoshi, Kimura, Nobuyuki, Murakami, Mami, Ohki, Emiko, Chao, Richard C., Imamura, Masayuki
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2013
Assuntos:
Phase II Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3771378/
https://ncbi.nlm.nih.gov/pubmed/23269537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-012-9910-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados